Oregon 2019 Regular Session Status: In Committee Bipartisan · 3 D · 1 R cosponsors

HB 2961 — Relating to a requirement to disclose wholesale pricing in prescription drug advertising.

Last action — In committee upon adjournment.

  1. ✓
    Introduced
  2. 2
    In Committee
  3. 3
    Passed House
  4. 4
    Passed Senate
  5. 5
    To Executive
  6. 6
    Enacted

This bill died with 2019 Regular Session. It reached “In Committee” and never advanced before the session ended, so it can no longer move — a new version would have to be reintroduced in the current session.

This bill is no longer active — its legislative session has ended, so there is no live prognosis. It would have to be reintroduced in the current session to move again.

Summary

Requires manufacturer to disclose in any advertisement for prescription drug wholesale price in Oregon of prescription drug. Imposes civil penalty for violation of requirement.

Bill Text

We don't have the full text on file for this bill yet.

Read HB 2961 on the official Oregon source →

Action History

  1. In committee upon adjournment.

  2. Public Hearing held.

  3. Referred to Health Care.

  4. First reading. Referred to Speaker's desk.

Sponsors

Sponsorship breakdown

Export CSV (upgrade) →

3 sponsors · 13 co-sponsors · 74 not signed on

Sponsors (3)

Co-sponsors (13)

Not signed on (74)

74 members have not signed on to this bill.

Show all 74 →

"Not signed on" means a member has not sponsored or co-sponsored this bill — it does not imply opposition. Members flagged Voted No have a recorded No vote on this bill.

Whip count is in markup. Polling the chamber and every recorded vote this session. Only the first open is slow. It’s instant for you after this. Calling the roll · Tallying · Engrossing

Subjects

healthcare health-insurance
Cross-referencing the record. Reading this bill against every other bill in the corpus by meaning, not keywords. Only the first open is slow. It’s instant for you after this. Matching · Ranking · Engrossing

Frequently asked questions

What does HB 2961 do?
Requires manufacturer to disclose in any advertisement for prescription drug wholesale price in Oregon of prescription drug. Imposes civil penalty for violation of requirement.
Who sponsors HB 2961?
HB 2961 is sponsored by Mark Meek (Democrat), Kim Wallan (Republican), Rob Nosse (Democrat), Tawna Sanchez (Democrat), Barbara Smith Warner, Karin Power, Brad Witt, Alissa Keny-Guyer, Teresa Alonso Leon, Anna Williams, Michael Dembrow, Sheri Schouten, Courtney Neron, Tiffiny Mitchell, Rachel Prusak, and Shemia Fagan.
What is the current status of HB 2961?
This bill died with 2019 Regular Session. It reached “In Committee” and never advanced before the session ended, so it can no longer move — a new version would have to be reintroduced in the current session.
Where can I track HB 2961?
Track HB 2961 free on One Click Politics — get push/email alerts when it moves.

Make your voice heard on HB 2961

Find the representatives who decide this bill and tell them where you stand — for yourself, or mobilize your whole list in one click with One Click Politics advocacy software.

Find my representatives → Run a campaign

Stay ahead of HB 2961

Last checked for changes 3 months ago · updated continuously

One Click Politics tracks every bill in Congress and all 50 states.

Track this bill →